BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29182572)

  • 1. Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics.
    Li Z; Guan M; Lin Y; Cui X; Zhang Y; Zhao Z; Zhu J
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29182572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface analysis of lipids by mass spectrometry: more than just imaging.
    Ellis SR; Brown SH; In Het Panhuis M; Blanksby SJ; Mitchell TW
    Prog Lipid Res; 2013 Oct; 52(4):329-53. PubMed ID: 23623802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma.
    Krautbauer S; Meier EM; Rein-Fischboeck L; Pohl R; Weiss TS; Sigruener A; Aslanidis C; Liebisch G; Buechler C
    Biochim Biophys Acta; 2016 Nov; 1861(11):1767-1774. PubMed ID: 27570113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
    Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
    J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover.
    Simon J; Ouro A; Ala-Ibanibo L; Presa N; Delgado TC; Martínez-Chantar ML
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma.
    Abel S; De Kock M; van Schalkwyk DJ; Swanevelder S; Kew MC; Gelderblom WC
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):391-9. PubMed ID: 19782547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
    Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice.
    Li S; Liu H; Jin Y; Lin S; Cai Z; Jiang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2369-75. PubMed ID: 21763219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential proteomic analysis of hepatocellular carcinoma.
    Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
    Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ammonia-treated N-(1-naphthyl) ethylenediamine dihydrochloride as a novel matrix for rapid quantitative and qualitative determination of serum free fatty acids by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
    Zhang Y; Wang Y; Guo S; Guo Y; Liu H; Li Z
    Anal Chim Acta; 2013 Sep; 794():82-9. PubMed ID: 23972979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice.
    Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
    Lipids Health Dis; 2021 Oct; 20(1):135. PubMed ID: 34629057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression.
    Ranjpour M; Wajid S; Jain SK
    Anticancer Agents Med Chem; 2019; 19(2):236-247. PubMed ID: 30324893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Depth Lipidomic Analysis of Molecular Species of Triacylglycerides, Diacylglycerides, Glycerophospholipids, and Sphingolipids of Buttermilk by GC-MS/FID, HPLC-ELSD, and UPLC-QToF-MS.
    Castro-Gómez P; Montero O; Fontecha J
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue and serum lipidome shows altered lipid composition with diagnostic potential in mycosis fungoides.
    Xu C; Zhou D; Luo Y; Guo S; Wang T; Liu J; Liu Y; Li Z
    Oncotarget; 2017 Jul; 8(29):48041-48050. PubMed ID: 28624795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS.
    Chen S; Yin P; Zhao X; Xing W; Hu C; Zhou L; Xu G
    Electrophoresis; 2013 Oct; 34(19):2848-56. PubMed ID: 24228263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.
    Patterson AD; Maurhofer O; Beyoglu D; Lanz C; Krausz KW; Pabst T; Gonzalez FJ; Dufour JF; Idle JR
    Cancer Res; 2011 Nov; 71(21):6590-600. PubMed ID: 21900402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
    Guo S; Qiu L; Wang Y; Qin X; Liu H; He M; Zhang Y; Li Z; Chen X
    Anal Bioanal Chem; 2014 Jul; 406(18):4357-70. PubMed ID: 24842401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive qualification and quantification of triacylglycerols with specific fatty acid chain composition in horse adipose tissue, human plasma and liver tissue.
    Guan M; Dai D; Li L; Wei J; Yang H; Li S; Zhang Y; Lin Y; Xiong S; Zhao Z
    Talanta; 2017 Sep; 172():206-214. PubMed ID: 28602296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.